Dr. Maysa Abu-Khalaf, MD
Claim this profileThomas Jefferson University Hospital
Studies Breast Cancer
Studies Breast cancer
12 reported clinical trials
26 drugs studied
Area of expertise
1Breast Cancer
Stage II
Stage III
HER2
2Breast Cancer
Stage III
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Maysa Abu-Khalaf, MD is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Time Restricted Eating
for Breast Cancer
This trial studies if intermittent fasting can improve outcomes for breast cancer patients with a BMI of 25 or higher who are receiving chemotherapy. The fasting involves not eating for a certain period and eating during another specific period each day. This approach may help control blood sugar and insulin levels, potentially reducing tumor growth. Intermittent fasting has been studied for its potential benefits in weight loss and managing cardiometabolic risk factors.
Recruiting1 award N/A10 criteria
More about Maysa Abu-Khalaf, MD
Clinical Trial Related6 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Maysa Abu-Khalaf, MD has experience with
- Paclitaxel
- ELU001
- Hyperthermia Treatment
- Olaparib
- Chemotherapy
- Short-Term Fasting
Breakdown of trials Maysa Abu-Khalaf, MD has run
Breast Cancer
Breast cancer
Ductal Carcinoma In Situ
Ovarian Disease
Uterine Disorder
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Maysa Abu-Khalaf, MD specialize in?
Maysa Abu-Khalaf, MD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage II patients, or patients who are Stage III.
Is Maysa Abu-Khalaf, MD currently recruiting for clinical trials?
Yes, Maysa Abu-Khalaf, MD is currently recruiting for 4 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Maysa Abu-Khalaf, MD has studied deeply?
Yes, Maysa Abu-Khalaf, MD has studied treatments such as Paclitaxel, ELU001, Hyperthermia Treatment.
What is the best way to schedule an appointment with Maysa Abu-Khalaf, MD?
Apply for one of the trials that Maysa Abu-Khalaf, MD is conducting.
What is the office address of Maysa Abu-Khalaf, MD?
The office of Maysa Abu-Khalaf, MD is located at: Thomas Jefferson University Hospital, Philadelphia, Pennsylvania 19107 United States. This is the address for their practice at the Thomas Jefferson University Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.